# Reactive Oxygen Species in the Pathogenesis of Diabetic Complications

> **NCT00703989** · NA · COMPLETED · sponsor: **Albert Einstein College of Medicine** · enrollment: 21 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DIETARY_SUPPLEMENT:** benfotiamine, α-lipoic acid

## Key facts

- **NCT ID:** NCT00703989
- **Lead sponsor:** Albert Einstein College of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2006-10
- **Final completion:** 2008-02
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2019-11-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00703989

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00703989, "Reactive Oxygen Species in the Pathogenesis of Diabetic Complications". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00703989. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*